Article
Efficacy and Safety of Palbociclib Plus Endocrine Therapy in Black and Hispanic Patients with Hormone Receptor Positive/human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer (HR+/HER2- ABC) Participating in the PALOMA Trials
Cancer Research / San Antonio Breast Cancer Symposium
(2022)
Abstract
C. Isaacs, F. Lynce, B. Sleckman, A. Castrellon, S. Kalmadi, K. Theall, X. Huang, E. Bananis, H. Rugo.Â
Disciplines
Publication Date
February 15, 2022
Citation Information
Reshma Mahtani. "Efficacy and Safety of Palbociclib Plus Endocrine Therapy in Black and Hispanic Patients with Hormone Receptor Positive/human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer (HR+/HER2- ABC) Participating in the PALOMA Trials" Cancer Research / San Antonio Breast Cancer Symposium Vol. 82 Iss. 4 Supplement (2022) Available at: http://works.bepress.com/reshma-mahtani/58/